91
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Development and External Validation a Novel Inflammation-Based Score for Acute Kidney Injury and Prognosis in Intensive Care Unit Patients

, , , , , & show all
Pages 2215-2226 | Published online: 02 Jun 2021

References

  • Hoste E, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14:607–625. doi:10.1038/s41581-018-0052-0
  • Kellum JA. Why are patients still getting and dying from acute kidney injury? Curr Opin Crit Care. 2016;22:513–519. doi:10.1097/MCC.0000000000000358
  • Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385:2616–2643. doi:10.1016/S0140-6736(15)60126-X
  • Collister D, Pannu N, Ye F, et al. Health care costs associated with AKI. Clin J Am Soc Nephrol. 2017;12:1733–1743. doi:10.2215/CJN.00950117
  • Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261:1207–1214. doi:10.1097/SLA.0000000000000732
  • Tanik VO, Cinar T, Velibey Y, et al. Neutrophil-to-lymphocyte ratio predicts contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. J Tehran Heart Cent. 2019;14:59–66.
  • Abu AM, Slotki I, Shavit L. Single emergency room measurement of neutrophil/lymphocyte ratio for early detection of acute kidney injury (AKI). Intern Emerg Med. 2018;13:717–725. doi:10.1007/s11739-017-1715-8
  • Velibey Y, Oz A, Tanik O, et al. Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2017;68:419–427. doi:10.1177/0003319716660244
  • Zheng C-F, Liu W-Y, Zeng -F-F, et al. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Crit Care. 2017;21(1):238. doi:10.1186/s13054-017-1821-z
  • Karabag Y, Cagdas M, Rencuzogullari I, et al. The C-reactive protein to albumin ratio predicts acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Lung Circ. 2019;28:1638–1645. doi:10.1016/j.hlc.2018.08.009
  • Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035. doi:10.1038/sdata.2016.35
  • Hu Y, Liu H, Fu S, Wan J, Li X. Red blood cell distribution width is an independent predictor of AKI and mortality in patients in the coronary care unit. Kidney Blood Press Res. 2017;42:1193–1204. doi:10.1159/000485866
  • Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259. doi:10.1158/1078-0432.CCR-04-0713
  • Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC. Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg. 2016;263:326–336. doi:10.1097/SLA.0000000000001122
  • Li Z, Li S, Ying X, et al. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer. 2020;23:540–549. doi:10.1007/s10120-019-01027-6
  • Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204. doi:10.1186/cc11454
  • McCullough PA, Shaw AD, Haase M, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:13–29.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Sato Y, Yanagita M. Immune cells and inflammation in AKI to CKD progression. Am J Physiol Renal Physiol. 2018;315:F1501–12.
  • Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi:10.1172/JCI45161
  • Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200. doi:10.1038/nrneph.2011.16
  • Li L, Huang L, Sung SS, et al. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol. 2007;178:5899–5911. doi:10.4049/jimmunol.178.9.5899
  • Day YJ, Huang L, Ye H, Li L, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol. 2006;176:3108–3114. doi:10.4049/jimmunol.176.5.3108
  • Hoke TS, Douglas IS, Klein CL, et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol. 2007;18:155–164. doi:10.1681/ASN.2006050494
  • Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012;82:516–524. doi:10.1038/ki.2012.208
  • Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 2016;311:F145–61. doi:10.1152/ajprenal.00164.2016
  • Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2007;21:20–27. doi:10.1038/sj.jhh.1002101
  • Mizushima T, Sasaki M, Ando T, et al. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G255–66. doi:10.1152/ajpgi.00264.2009
  • Teles F, Machado FG, Ventura BH, et al. Regression of glomerular injury by losartan in experimental diabetic nephropathy. Kidney Int. 2009;75:72–79. doi:10.1038/ki.2008.528
  • Arias SC, Valente CP, Machado FG, et al. Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy. PLoS One. 2013;8:e56215. doi:10.1371/journal.pone.0056215
  • Kayabasi H, Yilmaz Z, Sit D, Kadiroglu AK, Yilmaz E. The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis. Eur Rev Med Pharmacol Sci. 2013;17:235–242.
  • Shi L, Qin X, Wang H, et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget. 2017;8:18792–18801. doi:10.18632/oncotarget.13320
  • Cananzi F, Minerva EM, Sama L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119:12–20. doi:10.1002/jso.25290
  • Fan Z, Li Y, Ji H, Jian X. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study. BMJ Open. 2018;8:e23459. doi:10.1136/bmjopen-2018-023459
  • Chen H, Li M, Liu L, Dang X, Zhu D, Tian G. Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction. Medicine (Baltimore). 2019;98:e16267. doi:10.1097/MD.0000000000016267
  • Gittleman H, Sloan AE, Barnholtz-Sloan JS. An independently validated survival nomogram for lower-grade glioma. Neuro Oncol. 2020;22:665–674. doi:10.1093/neuonc/noz191
  • Liao F, Guo X, Lu X, Dong W. A validated survival nomogram for early-onset diffuse gastric cancer. Aging (Albany NY). 2020;12:13160–13171. doi:10.18632/aging.103406
  • He Y, Zhu Z, Chen Y, et al. Development and validation of a novel diagnostic nomogram to differentiate between intestinal tuberculosis and crohn’s disease: a 6-year Prospective Multicenter Study. Am J Gastroenterol. 2019;114:490–499. doi:10.14309/ajg.0000000000000064
  • Jiang Y, Yuan Q, Lv W, et al. Radiomic signature of (18) F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits. Theranostics. 2018;8:5915–5928. doi:10.7150/thno.28018